Valuation : China Isotope & Radiation Corporation

Market Cap 4.55B 5.3B 676M 583M 550M 501M 936M 63.89B 943M 6.51B 2.53B 32.66B 2.54B 2.48B 107B P/E 2024
8.03x
P/E 2025 17.7x
Enterprise Value 4.66B 5.44B 694M 599M 564M 514M 960M 65.56B 968M 6.68B 2.59B 33.52B 2.61B 2.55B 110B EV / Sales 2024
0.42x
EV / Sales 2025 0.82x
Free-Float
91.21%
Yield 2024
3.74%
Yield 2025 1.69%
Aug. 28 China Isotope & Radiation Corporation Announces Resignation of Zhang Junqi as an Executive Director, A Member of the Strategy Committee of the Board and A Member of the Science and Technology Innovation Committee of the Board, Effective August 28, 2026 CI
Aug. 28 China Isotope & Radiation Corporation Announces CEO Changes, Effective August 28, 2026 CI
Jul. 05 China Isotope to Form JV With Associate MT
Jul. 03 China Isotope & Radiation Corporation and CNNC Yuanke Enter into Shareholders? Agreement to Establish Joint Venture Company CNNC Fuyuan CI
Jun. 18 China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2025, Payable on Before 17 August 2026 CI
Jun. 18 China Isotope & Radiation Corporation Appoints Zhang Guoliang as A Member of Legal Affairs Committee of the Board and A Member of Science and Technology Innovation Committee of the Board CI
May. 26 China Isotope Proposes Auditor Change MT
May. 26 China Isotope & Radiation Corporation Announces Ma Xiaoyu Resignation of Ma Xiaoyu as an Executive Director Member of the Legal Affairs Committee Science and Technology Innovation Committee, Effective May 26, 2026 CI
Mar. 27 China Isotope & Radiation final cash dividend of RMB0.2264 per share RE
Mar. 27 China Isotope & Radiation Corporation Proposes Final Dividend for the Year Ended December 31, 2025, Payable Before 17 August 2026 CI
Mar. 27 China Isotope & Radiation Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 CI
Mar. 19 China Isotope & Radiation to buy 51% stake in Hunan Huifeng Engineering Detection RE
Mar. 13 China Isotope & Radiation Corporation, Zhonghe Headway and the People?s Government of Maoming Municipality Enter Strategic Cooperation Agreement CI
1 day-5.25%
1 week-7.70%
Current month-5.53%
1 month-7.75%
3 months-14.25%
6 months-24.83%
Current year-22.23%
1 week 15.56
Extreme 15.56
17.49
1 month 15.56
Extreme 15.56
17.98
Current year 15.56
Extreme 15.56
24.28
1 year 15.2
Extreme 15.2
25
3 years 9.03
Extreme 9.03
25
5 years 9.03
Extreme 9.03
26.5
10 years 9.03
Extreme 9.03
35.4
Manager TitleAgeSince
Corporate Secretary - 2024-08-29
Corporate Secretary - 2024-08-29
Comptroller/Controller/Auditor 52 2015-12-17
Director TitleAgeSince
Director/Board Member 57 2017-02-21
Director/Board Member 54 2019-06-27
Director/Board Member 54 2019-12-29
Change 5-day change 1-year change 3-year change Capi.($)
-5.25%-7.70%-6.49%+23.70% 676M
-0.82%-4.60%+145.17%+365.75% 21.88B
+0.36%+0.53%-35.62%-20.66% 10.31B
+2.78%-4.06%+361.11%+14.06% 8.03B
+0.08%-7.53%-32.17% - 7.01B
-0.07%-0.01%+82.33%+49.79% 6.58B
-0.10%-1.75%-18.67%-20.00% 5.92B
-0.10%-0.91%-10.51%-20.82% 4.38B
-1.39%+1.62%+74.42%+84.22% 4.26B
-0.42%-1.38%-19.61%-27.96% 2.8B
Average -0.49%-1.89%+54.00%+49.79% 7.19B
Weighted average by Cap. -0.04%-2.49%+85.27%+128.26%

Financials

2024 2025
Net sales 7.57B 8.84B 1.13B 972M 916M 835M 1.56B 106B 1.57B 10.84B 4.21B 54.44B 4.23B 4.14B 179B 7.19B 8.39B 1.07B 923M 869M 792M 1.48B 101B 1.49B 10.29B 3.99B 51.65B 4.02B 3.93B 170B
Net income 407M 475M 60.51M 52.2M 49.17M 44.8M 83.74M 5.72B 84.37M 582M 226M 2.92B 227M 222M 9.6B 327M 382M 48.72M 42.03M 39.59M 36.07M 67.43M 4.6B 67.93M 469M 182M 2.35B 183M 179M 7.73B
Net Debt -109M -127M -16.21M -13.98M -13.17M -12M -22.43M -1.53B -22.6M -156M -60.52M -783M -60.87M -59.53M -2.57B 119M 139M 17.68M 15.25M 14.37M 13.09M 24.47M 1.67B 24.66M 170M 66.03M 854M 66.4M 64.95M 2.81B
Logo China Isotope & Radiation Corporation
China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.
Employees
3,578
Date Price Change Volume
26-09-03 HK$15.71 -5.25% 127,000
26-09-02 HK$16.58 -0.12% 68,600
26-09-01 HK$16.60 -0.18% 75,200
26-08-31 HK$16.63 -2.18% 34,000
26-08-28 HK$17.00 -0.12% 46,800

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1763 Stock